Back to All
Group

Webinar: To Test or Not To Test – Avoiding Costly Planning Mistakes with Effective Dx Financial Pre-Launch Planning

26 May, 2016

Are you at the pre-launch or commercial implementation stage of planning for a therapy and diagnostic? This webinar provides insights on how to optimize your therapy launch to maximize the therapy's revenue opportunity. Listen to the webinar to learn:

  • About effective financial planning for integrating diagnostics into your targeted therapy commercial strategy; and
  • That through optimization of the diagnostic, pharma can predict the revenue and patient share losses and gains that can be made in key markets and maximize the return on investment for the therapy asset.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.